-
2025 Nutraceutical and Natural Product Industry Outlook: Insights from Nutritional Outlook’s Editorial Advisory Board
13 Jan 2025 17:53 GMT
… for holistic remedies over pharmaceuticals. This trend is expected to … for more natural alternatives to pharmaceuticals and medical procedures.
Sustainability: … pharmaceuticals and other therapies. This could have a substantial effect on the industry …
-
2025 predictions: Which trends are set to shape the biotech industry this year?
13 Jan 2025 18:55 GMT
… Zorlular, CEO of Er-Kim Pharmaceuticals. “In years past, logistical commercial … . These efforts highlight a broader industry shift towards delivering equitable healthcare … interesting year for the biotech industry, with political shifts potentially playing …
-
Swiss researchers turn CO2 into industrial chemical
13 Jan 2025 14:51 GMT
… researchers turn CO2 into an industrial chemical
Keystone-SDA
Listen to … acetaldehyde, which is valuable for industry. Acetaldehyde is used in the … the potential to change numerous industries, from pharmaceuticals to agriculture, according to …
-
BMA sets date for special LMC conference on stepping up industrial action
13 Jan 2025 14:20 GMT
-
Determining Recommended Acceptable Intake Limits for N-nitrosamine Impurities in Pharmaceuticals: Development and Application of the Carcinogenic Potency Categorization Approach
13 Jan 2025 13:53 GMT
… posed practical challenges to both industry and regulators, significantly impacting drug … for N-nitrosamine impurities in pharmaceuticals: Development and application of the …
-
Alignment Healthcare Announces Industry-Leading Membership Growth and Promotion of Dawn Maroney to President
13 Jan 2025 13:30 GMT
Achieves 35% year-over-year growth to 209,900 members on Jan. 1, showing how Medicare Advantage can be done right
Announces year-end 2025 health plan membership of 225,000 to 231,000 and reiterates confidence in achieving consensus adjusted EBITDA of $40 …
-
ORIC® Pharmaceuticals Provides Early Phase 1b Combination Data for ORIC-944, Operational Highlights for 2024, and Anticipated Upcoming Milestones
13 Jan 2025 13:05 GMT
… 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), … with the appointment of industry veteran Keith Lui as … event. About ORIC Pharmaceuticals, Inc.
ORIC Pharmaceuticals is a clinical … personnel; competition in the industry in which ORIC operates; …
-
ORIC Pharmaceuticals Announces Clinical Supply Agreement to Evaluate ORIC-114 in Combination with Amivantamab for the First-Line Treatment of NSCLC with EGFR Exon 20 Insertion Mutations
13 Jan 2025 13:00 GMT
… , 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical … antitumor activity. About ORIC Pharmaceuticals, Inc.
ORIC Pharmaceuticals is a clinical stage … management personnel; competition in the industry in which ORIC operates; general …
-
ARS Pharmaceuticals Announces Preliminary Fourth Quarter 2024 Financial Results and 2025 Objectives for neffy® (epinephrine nasal spray)
13 Jan 2025 13:00 GMT
Preliminary fourth quarter neffy® net product revenue of approximately $6.5 million Preliminary cash, cash equivalents and short-term investments of $314.0 million at year-end 2024 to support an operating runway of at least three years Company to present …
-
Salarius Pharmaceuticals and Decoy Therapeutics Announce Definitive Merger Agreement
13 Jan 2025 13:00 GMT
Decoy’s proprietary IMP3ACT™ peptide conjugate drug design and manufacturing platform leverages machine learning (ML) and artificial intelligence (AI) tools Decoy is leveraging non-dilutive funding and equivalents from federal governments, corporations and …
About
© 1995-2025